Guys , even if Amgen made their payment in Dec. , how would a "one-off payment "made by Amgen be classified as 'Receipts from customers" as that hardly meets the definition of "revenue from regular , on-going business activities .
I lean to the $17m not including a one-off payment from Amgen ....imo .
No doubt Oslo will argue that it also includes a payment from Abbvie !!
Q